1 in 3 Bharat Biotech Covaxin takers reported adverse events, finds BHU study
Advertisement
In light of growing concerns about COVID-19 vaccine safety, a comprehensive one-year follow-up study by Banaras Hindu University (BHU) researchers sheds light on the long-term effects of Bharat Biotech's Covaxin. This study aimed to assess adverse events of special interest (AESI) among vaccine recipients, providing crucial insights into the vaccine's safety profile.
The study included 635 adolescents and 291 adults, revealing that nearly one-third of the participants reported AESI. Among adolescents, common AESIs included new-onset skin and subcutaneous disorders (10.5%), general disorders (10.2%), and nervous system disorders (4.7%). In adults, the prevalent AESIs were general disorders (8.9%), musculoskeletal disorders (5.8%), and nervous system disorders (5.5%). Serious AESIs, such as stroke and Guillain-Barre syndrome, were reported in 1% of participants.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.